61 – 70 of 2261
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A deep learning approach to prediction of blood group antigens from genomic data
(
- Contribution to journal › Article
-
Mark
Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages : an EU COST Action cGvHD Eurograft project
(
- Contribution to journal › Letter
-
Mark
An uncommon MALady : is the AnWj puzzle complete?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8) : a prospective, multicentre, open-label, randomised, phase 3a trial
(
- Contribution to journal › Article
-
Mark
SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Historical perspective on von Willebrand disease
2024) p.1-6(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Textbook of von Willebrand Disease : Basic and Clinical Aspects
- Book/Report › Anthology (editor)
-
Mark
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
(
- Contribution to journal › Article
-
Mark
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
(
- Contribution to journal › Article
-
Mark
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells
(
- Contribution to journal › Article